标题
Obesity and type 2 diabetes: which patients are at risk?
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 14, Issue 5, Pages 399-408
出版商
Wiley
发表日期
2011-11-11
DOI
10.1111/j.1463-1326.2011.01536.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Diagnosis and Management of Prediabetes in the Continuum of Hyperglycemia—When do the Risks of Diabetes Begin? A Consensus Statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists
- (2013) Alan Garber et al. Endocrine Practice
- Inflammatory Mechanisms in Obesity
- (2011) Margaret F. Gregor et al. Annual Review of Immunology
- Type 2 diabetes risk in persons with dysglycemia: The Framingham Offspring Study
- (2011) Peter W.F. Wilson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A Structured Diet and Exercise Program Promotes Favorable Changes in Weight Loss, Body Composition, and Weight Maintenance
- (2011) Richard B. Kreider et al. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
- Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB
- (2011) Sudarshana Purkayastha et al. NATURE MEDICINE
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Factors associated with achieving a weight loss goal among participants in an adapted Diabetes Prevention Program
- (2011) Todd S. Harwell et al. Primary Care Diabetes
- Obesity-Related Quality-Adjusted Life Years Lost in the U.S. from 1993 to 2008
- (2010) Haomiao Jia et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Obesity Stigma: Important Considerations for Public Health
- (2010) Rebecca M. Puhl et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Adipose tissue inflammation and insulin resistance: all obese humans are not created equal: Figure 1
- (2010) Marie-Soleil Gauthier et al. BIOCHEMICAL JOURNAL
- The obese healthy paradox: is inflammation the answer?
- (2010) Nuria Barbarroja et al. BIOCHEMICAL JOURNAL
- The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals
- (2010) Matthias Blüher CURRENT OPINION IN LIPIDOLOGY
- Factors associated with the maintenance or achievement of the weight loss goal at follow-up among participants completing an adapted diabetes prevention program
- (2010) Karl K. Vanderwood et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Personal Responsibility And Obesity: A Constructive Approach To A Controversial Issue
- (2010) Kelly D. Brownell et al. HEALTH AFFAIRS
- The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes
- (2010) D. Russell-Jones INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Obesity stigma: A newly recognized barrier to comprehensive and effective type 2 diabetes management
- (2010) M. Elizabeth Teixeira et al. Journal of the American Academy of Nurse Practitioners
- Pre-Diabetes and the Risk for Cardiovascular Disease
- (2010) Earl S. Ford et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The evolving place of incretin-based therapies in type 2 diabetes
- (2010) Baptist Gallwitz PEDIATRIC NEPHROLOGY
- Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide
- (2010) Pinkney Therapeutics and Clinical Risk Management
- Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
- (2009) Matthew P. Gilbert et al. AMERICAN JOURNAL OF MEDICINE
- Translating the Diabetes Prevention Program
- (2009) M. Kaye Kramer et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
- Many Americans Have Pre-Diabetes and Should Be Considered for Metformin Therapy
- (2009) M. K. Rhee et al. DIABETES CARE
- Insulin Resistance, -Cell Dysfunction, and Conversion to Type 2 Diabetes in a Multiethnic Population: The Insulin Resistance Atherosclerosis Study
- (2009) C. Lorenzo et al. DIABETES CARE
- Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort
- (2009) J. A. Kolberg et al. DIABETES CARE
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- (2009) M. Marre et al. DIABETIC MEDICINE
- Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates
- (2009) Eric A. Finkelstein et al. HEALTH AFFAIRS
- Thrift: a guide to thrifty genes, thrifty phenotypes and thrifty norms
- (2009) J C K Wells INTERNATIONAL JOURNAL OF OBESITY
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors
- (2009) Goodarz Danaei et al. PLOS MEDICINE
- Role of Metformin for Weight Management in Patients Without Type 2 Diabetes
- (2008) Alicia R Desilets et al. ANNALS OF PHARMACOTHERAPY
- Adipokines: The missing link between insulin resistance and obesity
- (2008) B. Antuna-Puente et al. DIABETES & METABOLISM
- Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
- (2008) Alan Garber et al. LANCET
- The incretin system and its role in type 2 diabetes mellitus
- (2008) J HOLST et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity Epidemic
- (2008) Youfa Wang et al. Obesity
- Weight loss advice U.S. obese adults receive from health care professionals
- (2008) Jean Y. Ko et al. PREVENTIVE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started